1 active not recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Active not recruiting 1 |
Follow Tuberous Sclerosis Complex: new trials by email Literature Review of Tuberous Sclerosis Complex trials Research Report on Tuberous Sclerosis Complex
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Roll-over Study to Collect and Assess Long-term Safety of Everolimus in Patients With TSC and Refractory Seizures Who Have Completed the EXIST-3 Study [CRAD001M2304] and Who Are Benefitting From Continued Treatment everolimus - Tuberous Sclerosis Complex | Phase 3 | Active not recruiting | Novartis Pharmaceuticals | 206 | 2017-08-23 | 2026-08-21 |
Seizures (1) · Tuberous Sclerosis (1)
Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Hamartoma (1) · Heredodegenerative Disorders, Nervous System (1) · Malformations of Cortical Development (1) · Malformations of Cortical Development, Group I (1) · Neoplasms (1) · Neoplasms, Multiple Primary (1) · Neoplastic Syndromes, Hereditary (1) · Nervous System Diseases (1) · Nervous System Malformations (1) · Neurocutaneous Syndromes (1) · Neurodegenerative Diseases (1) · Neurologic Manifestations (1)
Everolimus (1)
Australia (1) · Belgium (1) · Canada (1) · Colombia (1) · France (1) · Hungary (1) · Italy (1) · Japan (1) · Mexico (1) · Poland (1) · Russia (1) · South Korea (1) · Spain (1) · Taiwan (1) · Thailand (1)